Center for Probe Development and Commercialization

The Center for Probe Development and Commercialization (CPDC) is a leading Canadian center of excellence focused on the discovery, development, and commercialization of next-generation radiopharmaceuticals. Established in 2008 and headquartered at McMaster University, CPDC operates as a full-service contract development and manufacturing organization (CDMO) specializing in molecular imaging probes and targeted radiotherapeutics. The organization bridges the gap between academic research and clinical application by providing GMP manufacturing, regulatory support, and clinical trial services to global pharmaceutical and biotech partners. CPDC has played a pivotal role in the radiopharmaceutical ecosystem, notably spinning out Fusion Pharmaceuticals and maintaining a robust supply chain for critical cancer diagnostics and treatments across North America.